Vicente Larraga
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Heterologous DNA-Adenovirus Prime-Boost Strategy Expressing Bluetongue Virus VP2 and VP7 Proteins Protects Against Virulent Challenge.
Journal: Vaccines
Published: August 24, 2025
Bivalent SARS-CoV-2 spike immunization with non-replicative antibiotic resistance-free DNA vaccine induces immunity to multiple virus variants.
Journal: Scientific reports
Published: May 05, 2025
An Overview of the Use of Nanoparticles in Vaccine Development.
Journal: Nanomaterials (Basel, Switzerland)
Published: May 04, 2023
A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis.
Journal: Frontiers in immunology
Published: April 27, 2023
Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2.
Journal: Frontiers in immunology
Published: September 02, 2022
Stable Episomal Transfectant Leishmania infantum Promastigotes Over-Expressing the DEVH1 RNA Helicase Gene Down-Regulate Parasite Survival Genes.
Journal: Pathogens (Basel, Switzerland)
Published: May 19, 2022
An insight into differential protein abundance throughout Leishmania donovani promastigote growth and differentiation.
Journal: International microbiology : the official journal of the Spanish Society for Microbiology
Published: May 01, 2022
Leishmania infantum UBC1 in Metacyclic Promastigotes from Phlebotomus perniciosus, a Vaccine Candidate for Zoonotic Visceral Leishmaniasis.
Journal: Vaccines
Published: December 14, 2021
New diarylsulfonamide inhibitors of Leishmania infantum amastigotes.
Journal: International journal for parasitology. Drugs and drug resistance
Published: October 13, 2020
Functional genomics in sand fly-derived Leishmania promastigotes.
Journal: PLoS neglected tropical diseases
Published: May 10, 2019
IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.
Journal: PloS one
Published: October 23, 2018
Last Updated: 09/26/2026